SCHEMBL6537426

SCHEMBL6537426

Cc1cnc2c(NC(=O)c3ccccc3C(F)(F)F)cccc2c1Cl

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGES O14684 16/20 0.50
NR3C1 P04150 2/20 0.49
RXFP1 Q9HBX9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537820 0.85 RXFP1 (0.45) PTGESNR3C1RXFP1
SCHEMBL6537982 0.84 PTGES (0.51) PTGESRXFP1
SCHEMBL6538002 0.83 RXFP1 (0.45) PTGESNR3C1RXFP1
SCHEMBL8488361 0.82 RXFP1 (0.47) PTGESRXFP1
SCHEMBL6538197 0.81 PTGES (0.43) PTGESRXFP1
SCHEMBL6537586 0.80 KDM4E (0.53)
SCHEMBL6537674 0.80 TYK2 (0.46)
SCHEMBL6538369 0.80 PTGES (0.44) PTGESNR3C1RXFP1
SCHEMBL6537621 0.79 SCN5A (0.42) PTGESRXFP1
SCHEMBL6538364 0.78 PTGES (0.45) PTGESRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed